July 19, 2016
Kenneth J. Snow, MD, MBA, remarks on why coverage for preventive measures is so valuable in diabetes and explains how his organization works with members to ensure that they understand risk factors for disease progression and take a proactive role in managing their condition.
June 27, 2016
Before ending their discussion in this program, Dennis P. Scanlon, PhD; Zachary T. Bloomgarden, MD, MACE; Robert Gabbay, MD, PhD, FACP; Michael Gardner, MD; and John A. Johnson, MD, MBA, share their final thoughts on optimizing care for patients with diabetes by addressing factors that affect overall management of the disease and its complications.
June 17, 2016
Even if they leave average cost the same, interventions that decrease cost variability have economic value.
May 17, 2016
Hybrid approaches allow for clinician input into case finding for care management, but training and monitoring is required to protect against unintentional biases.
May 4, 2016
The panelists, Drs Peter Salgo, John Kitchens, Steven Peskin, and Rishi Singh, provide additional insight on their expectations for the future of diabetes and management of eye-related complications.
August 18–20, 2014
September 6, 2014
October 17 - 18, 2014